Physician profile
Paul Kraemer
NPI 1770535411
$276,144.28
in general payments reported to CMS, 2019-2025
27 companies · $15K in 2025
The $15K reported for 2025 was more than what 75% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $52K · 2021: $62K · 2022: $44K · 2023: $14K · 2024: $10K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $23K · Consulting Fee: $11K · Food and Beverage: $3,238 · Travel and Lodging: $1,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $23,052.49 |
| Consulting Fee | $11,329.00 |
| Food and Beverage | $3,237.54 |
| Travel and Lodging | $1,346.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $81,230.77 | 2019-2025 | Pyrenees Cervical Plate System, Insignia, Everest Spinal System |
| Medtronic USA, INC. | $71,569.96 | 2019-2020 | |
| Globus Medical, INC. | $49,291.79 | 2019-2025 | Creo Mcs, Fenestrated, Sideloading, Creo |
| Medtronic, INC. | $39,751.14 | 2021-2025 | Catalyft Pl Expandable Interbody System, Zevo Anterior Cervical Plate System, Clydesdale Ptc Spinal System |
| Medical Device Business Services, INC. | $15,216.44 | 2019-2023 | Teligen, Spine & Trauma 3d Navigation |
| Intrinsic Therapeutics | $6,941.37 | 2021-2025 | Barricaid Acd (Annular Closure Device) |
| Zimmer Biomet Holdings, INC. | $6,189.63 | 2019-2021 | |
| Si-Bone, INC. | $3,765.00 | 2020-2021 | |
| Depuy Synthes Sales INC. | $512.53 | 2019-2025 | Cougar, Conduit |
| 4web, INC. | $500.00 | 2023 | Spine Truss System |
| Providence Medical Technology, INC. | $166.32 | 2019-2025 | |
| Carlsmed, INC. | $122.45 | 2024-2025 | Aprevo |
| Baxter Healthcare | $121.32 | 2022 | |
| Theragen, INC. | $102.00 | 2025 | Actastim-S |
| Alphatec Spine, INC | $94.97 | 2025 | Other - Miscellaneous |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossdsign USA Incorporated | $92.45 | 2025 | Ossdsign Catalyst |
| Depuy Synthes Products, INC. | $88.23 | 2022 | |
| Cerapedics INC. | $86.66 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Nanohive Medical LLC | $72.00 | 2025 | Hive Standalone Alif |
| Kerecis Limited | $58.61 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Augmedics INC. | $44.83 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.34 | 2025 | |
| Spineart USA INC | $25.91 | 2021 | |
| Abbott Laboratories | $24.08 | 2022 | |
| Vb Spine LLC | $20.71 | 2025 | Cascadia Interbody System |
| Mallinckrodt Enterprises LLC | $15.89 | 2019 | |
| Smith+Nephew, INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,350.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kraemer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.